ribociclib
novartis
['natalee']
#asco23 day 1: -8% gain in bc and all-cause mortality with os (#503) -audience question re cost and nnt for natalee study (3.3% gain in 3 yr idfs) (#lba500) -many prognostic indices in bc, few predictive -got lost: 1 blisters: 2 jetlag 
Mother, wife, runner | Oncologist researching #survivorship @FlindersHmri | Chair Psychosocial SG @CancerCareMASCC
Searching for meaning amidst chaos.